McAdams Wright Ragen Upgrades Dendreon (DNDN) to Hold
DNDN Hot Sheet
Rating Summary:3 Buy, 18 Hold, 7 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 11 | New: 38
McAdams Wright Ragen upgrades Dendreon (Nasdaq: DNDN) from Sell to Hold.
For more analyst ratings on DNDN click here.
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients.
For more analyst ratings on DNDN click here.
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients.
You May Also Be Interested In
- Canaccord Genuity Maintains a 'Hold' on Dendreon (DNDN) After Meeting with Management
- Guggenheim Initiates Coverage on Several Oil & Gas Drilling & Exploration Stocks; Upgrades DO & ESV, Lowers RDC
- Deutsche Bank Downgrades Nasdaq OMX Group Inc. (NDAQ) to Hold; Upgrading ICE on Lowered Expectations, Higher Volumes
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
